
Board of Directors
Bryan Roberts, Ph.D.
Bryan Roberts, Ph.D., is a member of the board of directors at Encoded Therapeutics and a partner at Venrock. He is currently involved with numerous public and private companies including Aledade, Devoted Health, Element Biosciences, Included Health, Interdict, Kelonia Therapeutics, Lyra Health, Moonlight Bio, Mythic Therapeutics, SmithRx and Suki.ai.
Past investments include 10x Genomics (NASDAQ: TXG), Ariosa Diagnostics (acquired by Roche), athenahealth (NASDAQ: ATHN), Fate Therapeutics (NASDAQ: FATE), and Ikaria (acquired by Mallinckrodt), among many others.
Bryan was named a Henry Crown Fellow by the Aspen Institute in 2006 and has ranked on Forbes’ Midas List twelve times, 2008 – 2020.
He holds a Ph.D. in Chemistry & Chemical Biology from Harvard University and received his B.A. from Dartmouth College.